ocugen_4C_LOGO (002).png
Ocugen Clinical Showcase Webcast Now Available
28 févr. 2024 08h00 HE | Ocugen
MALVERN, Pa., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and...
LOGO.png
GCANRx Announces Completion of Preclinical Study for Neuropsychiatric Cannabinoid Therapy
27 févr. 2024 07h45 HE | The Greater Cannabis Company, Inc.
BALTIMORE, MD, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Greater Cannabis Company, Inc. (“GCANRx” or the “Company”) (OTC: GCAN) a biopharmaceutical company pioneering development of next generation...
ocugen_4C_LOGO (002).png
Ocugen Chairman and CEO to present at Abu Dhabi Family Office Summit
26 févr. 2024 08h30 HE | Ocugen
MALVERN, Pa., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene...
Logo 1.png
Leading Independent Proxy Advisory Firm ISS Recommends Aeterna Zentaris and Ceapro Securityholders Vote FOR the Arrangement Agreement to Approve the Merger of Equals to Create a Diversified Biopharmaceutical Company
26 févr. 2024 07h30 HE | Aeterna Zentaris Inc
ISS states in its Aeterna Zentaris FOR recommendation that “on balance, the deal has strong strategic merit, third party solicitation was unable to generate any other actionable proposals, and...
finacialnews-logo-final-01 (2).png
Global Fibromyalgia Treatment Market Expected to Reach $4.6 billion by 2032
15 févr. 2024 08h45 HE | FN Media Group LLC
PALM BEACH, Fla., Feb. 15, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - Numerous reports indicate that the fibromyalgia treatment market is positioned to continue to grow at a...
ocugen_4C_LOGO (002).png
Ocugen to Host Clinical Showcase in New York City on Wednesday, February 21, 2024
14 févr. 2024 07h30 HE | Ocugen
Highlighting updates on OCU400 Phase 3 clinical trial starting early 2024 Featuring thought leaders in gene therapy and OCU400 Phase 1/2 clinical trial patient MALVERN, Pa., Feb. 14, 2024 ...
Emergen logo.png
Membrane chromatography Market Size Worth USD 1,611.9 Million in 2032 | Emergen Research
31 janv. 2024 08h07 HE | Emergen Research
Vancouver, Jan. 31, 2024 (GLOBE NEWSWIRE) --  The global membrane chromatography market size was USD 320.0 Million in 2022 and is expected to register a rapid revenue CAGR of 17.6% during the...
ocugen_4C_LOGO (002).png
Ocugen to Present at Pharma Market Research Conference
31 janv. 2024 08h00 HE | Ocugen
MALVERN, Pa., Jan. 31, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and...
finacialnews-logo-final-01 (2).png
Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030
30 janv. 2024 09h15 HE | FN Media Group LLC
PALM BEACH, Fla., Jan. 30, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - Recent reports show that the Multiple myeloma Diagnostic market will continue to grow in the next several years....
Transparency Market Research
Stem Cell Assays Market Size & Share to Surpass USD 8.5 billion by 2033 | Analysis by Transparency Market Research
18 janv. 2024 09h30 HE | Transparency Market Research
Wilmington, Delaware, United States, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global stem cell assays market is estimated to flourish at a CAGR of 16.5% from 2023 to...